Epilepsy Ireland are proud to support the ‘Patients Deserve Better’ campaign.
The campaign has been devised by our colleagues in the Neurological Alliance of Ireland. The campaign aims to highlight the importance of neurology nurse posts across Ireland and crucially, is calling for action to increase neurology nurse capacity in our health service.
**This survey has now closed; thank you for your responses.**
International Epilepsy Day takes place next year on the 14th February 2022.
Epilepsy Ireland members and service users are invited to attend an upcoming workshop on Patient & Public Involvement (PPI) in research.
The workshop will take place on October 6th from 10:30am – 2:00pm and is jointly organised by our colleagues in FutureNeuro and EBRA (European Brain Research Area).
Our colleagues in Rare Disease Ireland (RDI) are currently seeking feedback from people living with rare conditions about their experience of accessing diagnosis, treatment and care in Ireland.
While epilepsy is not rare, there are rare forms of the condition. In addition, epilepsy can also be a feature of other rare conditions.
We are delighted to be inviting research proposals as part of our 8th Research Call under our Research Funding Scheme.
A new module on seizures has been added to the HSE's eLearning platform HSeLanD.
HSeLanD contains over 200 eLearning programmes that is only available to HSE professionals.
The new module on seizures is very much welcomed and will provide education and awareness on two key aspects of seizure management for healthcare professionals:
New research recently published in leading Epilepsy Medical journal, Epilepsia, has reported positive results on the use of FINTEPLA® (Fenfluramine) in the treatment of Dravet Syndrome.
Our ongoing campaign around improved access to Free Travel for people with epilepsy has been featured as part of the Disability Federation of Ireland’s pre-budget submission.
A new study which investigated the awareness, knowledge, and practice of healthcare professionals in implementing the Sodium Valproate (Epilim) Pregnancy Prevention Program (PPP) has been published in the medical journal Expert Opinion on Drug Safety.
One of our key objectives at Epilepsy Ireland is "to undertake, encourage, fund and communicate research into the causes of, cures for and management of epilepsy and into the social and psychological effects of the condition".